scholarly article | Q13442814 |
P2093 | author name string | Usha Dutta | |
P2860 | cites work | Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma. | Q30375639 |
Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. | Q31146348 | ||
Biliary tract cancers. | Q33760399 | ||
Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China | Q33814914 | ||
Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study | Q33827569 | ||
Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates | Q34186338 | ||
Epidemiology and molecular pathology of gallbladder cancer | Q34473041 | ||
Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India | Q34602274 | ||
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer | Q34618537 | ||
Nutrition and the immune system from birth to old age. | Q34763499 | ||
Strategies for surgical treatment of gallbladder carcinoma based on information available before resection | Q35177785 | ||
Current management of gallbladder carcinoma | Q35583920 | ||
Gallbladder cancer: lessons from a rare tumour | Q35877178 | ||
Gallbladder cancer worldwide: geographical distribution and risk factors | Q36362499 | ||
Application of modern imaging methods in diagnosis of gallbladder cancer | Q36488822 | ||
Preneoplastic lesions in gallbladder cancer | Q36488825 | ||
Surgical strategies in patients with gallbladder cancer: nihilism to optimism | Q36488853 | ||
Diagnosis and surgical management of gallbladder cancer: a review | Q36806456 | ||
Emerging drugs for biliary cancer | Q36989921 | ||
The production of oxysterols in bile by activated human leukocytes | Q37067300 | ||
Systemic therapy for biliary tract cancers | Q37151623 | ||
Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options | Q37305176 | ||
A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour | Q37406450 | ||
Endoscopic ultrasound in the evaluation of radiologic abnormalities of the liver and biliary tree | Q37413479 | ||
Diagnosis of biliary tract and ampullary carcinomas | Q37478201 | ||
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment | Q37478218 | ||
Gallbladder cancer: a morphological and molecular update. | Q37505245 | ||
Management of gallbladder cancer | Q37755758 | ||
Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities | Q37833005 | ||
Diagnosis of gallbladder tumors | Q37882943 | ||
Epidemiology of biliary tract cancers: an update | Q38455094 | ||
Gallbladder cancer: incidence and survival in a high-risk area of Chile | Q39933588 | ||
Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder | Q40625152 | ||
A new method to establish the rational extent of hepatic resection for advanced gallbladder cancer using dye injection through the cystic artery | Q42038384 | ||
Targeted medical therapy of biliary tract cancer: recent advances and future perspectives | Q42635172 | ||
p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis | Q42863233 | ||
Expression of human telomerase catalytic protein in gallbladder carcinogenesis | Q43009940 | ||
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma | Q43207600 | ||
Carcinoma of the gallbladder. Staging, treatment, and prognosis | Q44360709 | ||
Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer | Q44933250 | ||
Childbearing, breastfeeding, other reproductive factors and the subsequent risk of hospitalization for gallbladder disease | Q45016704 | ||
Do the progesterone receptors have a role to play in gallbladder cancer? | Q45275928 | ||
Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease | Q46112186 | ||
Endoscopic ultrasound-guided FNA biopsy of bile duct and gallbladder: analysis of 53 cases | Q46897487 | ||
Endoscopic retrograde cholangiopancreatography in the evaluation of anomalous junction of the pancreaticobiliary duct and related disorders | Q47230253 | ||
The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. | Q50154059 | ||
Gallbladder cancer in India: a dismal picture | Q50157876 | ||
The natural history of gallstones: the GREPCO experience. The GREPCO Group | Q50175791 | ||
Gallbladder polyps: how to pick up the sinister ones | Q50180813 | ||
Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasion | Q50186190 | ||
Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples | Q50186481 | ||
Advanced gallbladder cancer: Indian "middle path". | Q50189853 | ||
Helicobacter pylori in areas of gastric metaplasia in the gallbladder and isolation of H. pylori DNA from gallstones. | Q50466381 | ||
β-Glucuronidase Catalyzed Hydrolysis of Benzo[ a ]pyrene-3-Glucuronide and Binding to DNA | Q53587057 | ||
Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. | Q54331175 | ||
Gallbladder cancer | Q57646726 | ||
Gallbladder carcinoma | Q57823528 | ||
P433 | issue | 4 | |
P921 | main subject | gallbladder cancer | Q977787 |
P304 | page(s) | 642-653 | |
P577 | publication date | 2012-04-01 | |
P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
P1476 | title | Gallbladder cancer: can newer insights improve the outcome? | |
P478 | volume | 27 |
Q35962779 | 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway |
Q36498478 | A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? |
Q40492655 | A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population |
Q34540184 | Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent |
Q53248168 | BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma. |
Q30402990 | Clinical, pathological and sonographic characteristics of unexpected gallbladder carcinoma. |
Q45032809 | Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression |
Q36132324 | Diagnosis and management of gallbladder cancer |
Q40226063 | Diagnostic nomogram for gallbladder wall thickening mimicking malignancy: using contrast-enhanced ultrasonography or multi-detector computed tomography? |
Q102206684 | Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme |
Q47649561 | Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines |
Q64234361 | Fine-needle aspiration cytology of gallbladder with an attempt of cytomorphological classification |
Q26784174 | Gallbladder Cancer in the 21st Century |
Q57653775 | Gallbladder cancer |
Q37635412 | Gallbladder cancer: epidemiology and outcome |
Q43169383 | Gallbladder carcinoma: Prognostic factors and therapeutic options |
Q40808689 | IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients |
Q96165904 | MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth |
Q35627069 | MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma |
Q50592271 | MicroRNA signatures in total peripheral blood of gallbladder cancer patients. |
Q99638639 | Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by downregulating PRKCE |
Q38989068 | PCBP1 is an important mediator of TGF-β-induced epithelial to mesenchymal transition in gall bladder cancer cell line GBC-SD. |
Q92638951 | PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway |
Q50178069 | Predictors of incidental gallbladder cancer in elderly patients. |
Q33594961 | Proteomic identification of tumor biomarkers associated with primary gallbladder cancer |
Q37501085 | Response of BRCA1-mutated gallbladder cancer to olaparib: A case report |
Q51318134 | Risk factors for gallbladder cancer: a case-control study. |
Q26744704 | Role of laparoscopy in hepatobiliary malignancies |
Q99407136 | Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells |
Q58101146 | Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review |
Q89768092 | TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway |
Q33613734 | Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo |
Q52669353 | Tea polyphenols induce S phase arrest and apoptosis in gallbladder cancer cells. |
Q96647193 | The lnc-CITED2-2:1 inhibits metastasis via inhibiting CITED2 and epithelial-mesenchymal transition in gallbladder cancer |
Q37694682 | The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer |
Q99411163 | Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway |
Q91678651 | Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC |
Q39078312 | WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA. |
Q64121611 | aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1 |